ELC
Edgar Lomax Company Portfolio holdings
AUM
$1.58B
This Quarter Return
+4.5%
1 Year Return
+13.93%
3 Year Return
+40.41%
5 Year Return
+102.62%
10 Year Return
+180.01%
AUM
$1.61B
AUM Growth
+$1.61B
(+0.34%)
Cap. Flow
-$57.9M
Cap. Flow
% of AUM
-3.6%
Top 10 Holdings %
Top 10 Hldgs %
40.15%
Holding
64
New
1
Increased
1
Reduced
58
Closed
3
Top Buys
| 1 |
Organon & Co
OGN
|
$1.72M |
Top Sells
| 1 |
CVS Health
CVS
|
$2.96M |
| 2 |
MetLife
MET
|
$2.79M |
| 3 |
Allstate
ALL
|
$2.59M |
| 4 |
Cisco
CSCO
|
$2.48M |
| 5 |
Verizon
VZ
|
$2.4M |
Sector Composition
| 1 | Healthcare | 24.25% |
| 2 | Financials | 18.28% |
| 3 | Technology | 10.27% |
| 4 | Consumer Staples | 9.91% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
MetLife
MET
$53.6B
| $85.9M | 5.34% |
1,434,851
-46,650
| -3% | -$2.79M |
|
|
2
CVS Health
CVS
$94B
| $78.5M | 4.88% |
941,339
-35,526
| -4% | -$2.96M |
|
|
3
Allstate
ALL
$53.6B
| $71.3M | 4.43% |
546,583
-19,875
| -4% | -$2.59M |
|
4
Exxon Mobil
XOM
$489B
| $68.7M | 4.27% |
1,089,792
-35,950
| -3% | -$2.27M |
|
|
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
| $68.2M | 4.24% |
1,296,355
-44,475
| -3% | -$2.34M |
|
|
6
Cisco
CSCO
$268B
| $66.2M | 4.11% |
1,249,403
-46,825
| -4% | -$2.48M |
|
7
Chevron
CVX
$326B
| $64.2M | 3.99% |
612,472
-20,800
| -3% | -$2.18M |
|
|
8
Verizon
VZ
$185B
| $50.1M | 3.11% |
894,666
-42,790
| -5% | -$2.4M |
|
9
General Dynamics
GD
$87.3B
| $48.8M | 3.03% |
259,449
-5,155
| -2% | -$970K |
|
10
Merck
MRK
$214B
| $44.3M | 2.75% |
569,530
-14,950
| -3% | -$1.16M |
|
11
Coca-Cola
KO
$297B
| $44.3M | 2.75% |
817,882
-31,150
| -4% | -$1.69M |
|
12
UnitedHealth
UNH
$280B
| $41.2M | 2.56% |
102,850
-1,670
| -2% | -$669K |
|
13
Exelon
EXC
$43.8B
| $39.8M | 2.47% |
897,111
-35,600
| -4% | -$1.58M |
|
14
AT&T
T
$208B
| $39.4M | 2.45% |
1,369,797
-62,684
| -4% | -$1.8M |
|
15
Union Pacific
UNP
$132B
| $38.7M | 2.41% |
176,050
-7,400
| -4% | -$1.63M |
|
16
IBM
IBM
$225B
| $38.5M | 2.39% |
262,372
-9,880
| -4% | -$1.45M |
|
17
3M
MMM
$82.2B
| $37.6M | 2.33% |
189,170
-7,300
| -4% | -$1.45M |
|
18
Johnson & Johnson
JNJ
$429B
| $37.2M | 2.31% |
225,825
-6,025
| -3% | -$993K |
|
19
Amgen
AMGN
$154B
| $34.7M | 2.15% |
142,295
-6,875
| -5% | -$1.68M |
|
20
AbbVie
ABBV
$374B
| $32M | 1.99% |
283,658
-6,775
| -2% | -$763K |
|
21
Goldman Sachs
GS
$221B
| $31.3M | 1.94% |
82,428
-3,237
| -4% | -$1.23M |
|
22
Pfizer
PFE
$142B
| $30.9M | 1.92% |
788,540
-13,065
| -2% | -$512K |
|
23
Walmart
WMT
$781B
| $30.2M | 1.88% |
214,040
-10,275
| -5% | -$1.45M |
|
24
Procter & Gamble
PG
$370B
| $29.9M | 1.86% |
221,675
-10,440
| -4% | -$1.41M |
|
25
Oracle
ORCL
$633B
| $26.2M | 1.63% |
336,565
-12,775
| -4% | -$994K |
|